{
    "nct_id": "NCT04092452",
    "official_title": "A PHASE 2A, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 16-WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF PF-06650833, PF-06700841, AND PF-06826647 IN ADULTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA",
    "inclusion_criteria": "* male or female participants, between 18-75, with a diagnosis of moderate to severe Hidradenitis Suppurativa\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* History of human immunodeficiency virus (HIV) or positive HIV serology at screening,\n* Infected with hepatitis B or hepatitis C viruses.\n* Have evidence of active or latent or inadequately treated infection with Mycobacterium tuberculosis (TB)",
    "miscellaneous_criteria": ""
}